Recombinant Danio rerio Paired box protein Pax-6 (pax6a)

Shipped with Ice Packs
In Stock

Description

Definition and Overview of Recombinant Danio rerio Paired Box Protein Pax-6 (Pax6a)

Recombinant Danio rerio (zebrafish) Paired Box Protein Pax-6 (Pax6a) is a genetically engineered transcription factor produced to study the molecular mechanisms underlying eye, brain, and pancreas development. Pax6a is one of two zebrafish paralogs (pax6a and pax6b) resulting from a teleost-specific whole-genome duplication event . This protein retains conserved DNA-binding domains (paired domain and homeodomain) critical for regulating gene expression during embryogenesis .

Domain Architecture

DomainAmino Acid RangeFunction
Paired domain (PD)1–128Binds DNA via helix-turn-helix motifs; essential for lens/retina development
Homeodomain (HD)215–277Enhances DNA-binding specificity; critical for transcriptional regulation
Proline-Serine-Threonine (PST) region317–437Transactivation domain; regulates target gene expression

Developmental Regulation

  • Eye Development: Pax6a synergizes with SOX2 to activate lens-specific enhancers (e.g., δ-crystallin DC5 enhancer), forming ternary DNA-protein complexes essential for lens placode initiation .

  • Neural Development: Expressed in telencephalon, diencephalon, and spinal cord; regulates neurogenesis .

  • Subfunctionalization: Unlike pax6b (retina/pancreas-enriched), pax6a governs broader neural and lens development .

Comparative Roles of Zebrafish Pax6 Paralogs

FeaturePax6aPax6b
Expression DomainsLens, telencephalon, spinal cordRetina, pancreas, midbrain-hindbrain boundary
Regulatory ElementsRetains brain-specific enhancers Lacks upstream pancreas enhancers
Mutant PhenotypeMicrophthalmia, brain defects Retinal dysplasia, pancreatic defects

Key Studies Using Recombinant Pax6a

  • DNA-Binding Assays: Demonstrates cooperative binding with SOX2 to lens enhancers, forming high-mobility ternary complexes .

  • Transgenic Analysis: Used to dissect enhancer activity (e.g., HS5 and NRE) in zebrafish, revealing cell-type-specific regulatory roles .

  • Morpholino Knockdown: Reduces eye size in zebrafish, confirming functional conservation with mammalian PAX6 .

Production and Quality Control

Recombinant Pax6a is typically produced in E. coli or yeast systems :

  • Expression: Induced with IPTG in BL21(DE3) cells.

  • Purification: Nickel-affinity chromatography under denaturing conditions .

  • Validation: Western blot with anti-Pax6 antibodies; functional assays for DNA binding .

Quality Metrics

ParameterResult
Endotoxin Level<1.0 EU/μg
StabilityStable at -80°C
ActivityConfirmed via EMSA

Implications for Evolutionary and Biomedical Research

  • Evolution: Subfunctionalization of pax6a/pax6b illustrates how gene duplication enables regulatory diversification in vertebrates .

  • Disease Models: Used to study aniridia and microphthalmia mechanisms, mirroring human PAX6 haploinsufficiency disorders .

References (Integrated Citations)

  • Structural insights:

  • Functional assays:

  • Evolutionary context:

Product Specs

Form
Lyophilized powder. We will ship the available format, but please note any format requirements when ordering, and we will try to accommodate them.
Lead Time
Delivery times vary by purchase method and location. Contact your local distributor for specific delivery details. All proteins are shipped with standard blue ice packs. Request dry ice shipment in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
pax6a; pax[zf-a]; paxzf-a; si:dkeyp-46c10.1Paired box protein Pax-6; Pax[Zf-a]
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-437
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Danio rerio (Zebrafish) (Brachydanio rerio)
Target Names
pax6a
Target Protein Sequence
MPQKEYYNRA TWESGVASMM QNSHSGVNQL GGVFVNGRPL PDSTRQKIVE LAHSGARPCD ISRILQVSNG CVSKILGRYY ETGSIRPRAI GGSKPRVATP EVVGKIAQYK RECPSIFAWE IRDRLLSEGV CTNDNIPSVS SINRVLRNLA SEKQQMGADG MYEKLRMLNG QTGTWGTRPG WYPGTSVPGQ PNQDGCQQSD GGGENTNSIS SNGEDSDETQ MRLQLKRKLQ RNRTSFTQEQ IEALEKEFER THYPDVFARE RLAAKIDLPE ARIQVWFSNR RAKWRREEKL RNQRRQASNS SSHIPISSSF STSVYQPIPQ PTTPVSFTSG SMLGRSDTAL TNTYSALPPM PSFTMANNLP MQPSQTSSYS CMLPTSPSVN GRSYDTYTPP HMQAHMNSQS MAASGTTSTG LISPGVSVPV QVPGSEPDMS QYWPRLQ
Uniprot No.

Target Background

Function
Transcription factor with localized expression in the neural tube during embryonic development.
Gene References Into Functions
1. Pax6 is initially widespread in the zebrafish anterior neural plate, including presumptive eye fields and dorsal diencephalon. After optic vesicle evagination, Pax6 is restricted to proliferating retinal cells. (PMID: 27747397) 2. Pax6 has a conserved role in establishing Shh expression in the vertebrate mid-diencephalic organizer. (PMID: 24528677) 3. Loss of Pax6b or Hb9 leads to insulin expression loss, revealing crosstalk between early beta-cell differentiation regulators. (PMID: 22426004) 4. Zebrafish Pax6.2 depletion results in a "small eye" phenotype, suggesting a role in retinal development. (PMID: 23359656) 5. Decreased Pax6 may permit axon regeneration and searching, while higher Pax6 levels are linked to topographical restoration. (PMID: 16973301) 6. Pax6 may act as a signaling molecule with non-cell autonomous activity. (PMID: 17229313) 7. Duplicate pax6a and pax6b, post-teleost genome duplication, encode transcription factors for eye, brain, olfactory system, and pancreas development. (PMID: 18282108) 8. Pax6 self-interacts via paired and homeodomains, leading to superactivation of Pax6-mediated transactivation. (PMID: 11069920)
Database Links

KEGG: dre:30567

STRING: 7955.ENSDARP00000115545

UniGene: Dr.24244

Protein Families
Paired homeobox family
Subcellular Location
Nucleus.
Tissue Specificity
Spatially restricted regions of the neural tube.

Q&A

What are the known expression patterns of pax6a in Danio rerio?

Zebrafish pax6a shows a distinct spatiotemporal expression pattern that partially overlaps with, yet differs from, its paralog pax6b. In the telencephalon at 5 days post-fertilization (dpf), pax6a is strongly expressed in the olfactory bulb, where pax6b is notably absent . In the subpallium, both paralogs are co-expressed in more caudal regions, while at supracommissural levels, only pax6a is detected .

In the developing eye, both pax6a and pax6b are expressed, as confirmed by RT-PCR analysis of 6-month-old wild-type zebrafish . Importantly, pax6a expression is completely absent from the developing and adult pancreas, where only pax6b transcripts are detected . This differential expression pattern strongly supports the subfunctionalization model, where duplicated genes divide the ancestral gene's functions between them.

How does pax6a differ functionally from pax6b in zebrafish?

The functional differences between pax6a and pax6b stem from both their divergent expression patterns and potential differences in protein function:

  • Tissue specificity: pax6a functions primarily in the brain (especially the olfactory bulb and specific telencephalic regions) and eye development, while pax6b has additional functions in pancreatic development .

  • Regulatory divergence: Reporter transgenic studies in both mouse and zebrafish reveal that pax6a and pax6b have undergone subfunctionalization through loss and retention of specific cis-regulatory elements . This correlates strongly with their diverged expression patterns.

  • Functional redundancy: Despite their differences, the paralogs exhibit some functional redundancy. The relatively mild phenotype observed in the pax6b "sunrise" mutant emphasizes role-sharing between the co-orthologues .

  • Experimental evidence: Simultaneous knockdown of both pax6a and pax6b using morpholinos disrupts eye development, leading to microphthalmia and general developmental delay, indicating their joint requirement for proper eye formation .

What conserved domains are present in Danio rerio pax6a protein?

Pax6a, like its human ortholog, contains highly conserved DNA-binding domains that are critical for its function as a transcription factor:

DomainFunctionConservation
Paired domainPrimary DNA-binding domainHighly conserved across vertebrates
HomeodomainSecondary DNA-binding domainHighly conserved, critical for target specificity
C-terminal transactivation domainActivation of transcriptionModerately conserved

The paired domain and homeodomain are particularly crucial for DNA binding specificity. Deep mutational scanning studies on human PAX6 have revealed that mutations in these domains can cause sequence-specific effects on DNA binding, including potential gain-of-function variants . Similar effects would be expected in zebrafish pax6a given the high conservation of these domains.

What methods are most effective for CRISPR-Cas9-mediated tagging of pax6a?

For efficient CRISPR-Cas9-mediated tagging of pax6a in zebrafish, several technical parameters significantly impact success rates:

  • Donor template selection: Using long single-stranded DNA (lssDNA) as a donor template combined with CRISPR-Cas9 ribonucleoprotein complex provides efficient knock-in of ~200 base-pair sequences encoding composite tags .

  • Strand choice impact: For pax6a knock-in, strand selection is crucial, though strand preference varies among target loci. Experimental testing of both target and non-target strand donors is recommended for optimal results .

  • Homology arm length optimization: Shorter 3' homology arms (50-nt) yield higher knock-in efficiency than longer arms (300-nt) for pax6a. The following efficiency data was observed:

    Donor Template5' Junction Frequency3' Junction FrequencyGermline Transmission
    Target strand (short 3' arm)HigherHigherHigher
    Target strand (long 3' arm)LowerLowerLowest (~22%)
  • Distance considerations: The distance between the CRISPR-Cas9 cleavage site and the tag insertion site significantly impacts precise editing success. For pax6a, a 10-nt distance resulted in lower rates of precise editing compared to targets with shorter distances (e.g., 2-nt for sox3) .

  • Sequence characteristics: Homopolymeric sequences (like TTTTT/AAAAA repeats) in the pax6a homology arms can adversely affect the repair process, resulting in imprecise editing .

How can subfunctionalization between pax6a and pax6b be experimentally demonstrated?

Demonstrating subfunctionalization between pax6a and pax6b requires multi-faceted experimental approaches:

  • Comparative expression analysis: Perform high-resolution spatiotemporal expression mapping using techniques like fluorescent in situ hybridization (FISH) combined with immunohistochemistry to precisely map where and when each paralog is expressed .

  • Paralog-specific knockout/knockdown: Generate paralog-specific mutants using CRISPR-Cas9 or morpholino knockdown to assess their individual contributions to development. Previous studies have shown that simultaneous knockdown of both paralogs disrupts eye development , but paralog-specific effects need further characterization.

  • Regulatory element analysis: Identify and test cis-regulatory elements specific to each paralog through:

    • Comparative genomic analysis

    • Reporter transgenic studies with candidate enhancers

    • Chromatin accessibility assays (ATAC-seq, DNase-seq) to identify active regulatory regions

  • Rescue experiments: Test the ability of one paralog to rescue the loss of the other through mRNA injection or transgenic expression. The degree of rescue provides insight into functional equivalence versus divergence.

  • Protein-DNA binding specificity: Assess whether pax6a and pax6b have evolved different DNA-binding preferences using techniques like SELEX-seq or ChIP-seq to map genome-wide binding profiles in vivo.

How does the synteny around pax6a differ from that of pax6b and what are the functional implications?

The syntenic relationships around pax6a and pax6b in zebrafish provide critical insights into their evolutionary history and functional divergence:

  • Disrupted synteny: Meticulous mapping of isolated BACs has identified perturbed synteny relationships around the duplicate genes . This genomic reorganization has significant functional implications.

  • Loss of neighboring genes: The pax6a locus has lost the coding region of its immediate neighbors, which are present in most vertebrate PAX6 loci . This includes the loss of exons from ELP4, a ubiquitously expressed neighbor gene that in most vertebrates contains important pax6 regulatory elements within its introns .

  • Regulatory element conservation: Despite the loss of neighboring coding regions, pax6a retains most of the brain-specific regulatory domains. This selective retention of regulatory elements demonstrates the mechanisms of subfunctionalization .

  • 3' control sequences: Functional conservation of pax6 downstream (3') control sequences is particularly noteworthy. In most vertebrates, these sequences reside within the introns of ELP4 . The preservation of these regulatory elements despite the loss of ELP4 exons highlights their evolutionary importance.

GeneSyntenic NeighborsRetained Regulatory ElementsLost Regulatory Elements
pax6aLost ELP4 exonsMost brain-specific enhancersPancreas enhancers
pax6bModified syntenyPancreas enhancersSome brain enhancers

This differential retention of regulatory elements directly correlates with the diverged expression patterns of the paralogs, providing clear evidence for evolution by subfunctionalization .

What are the optimal parameters for generating functional tagged versions of recombinant Danio rerio Pax6a protein?

Creating functional tagged versions of recombinant pax6a requires careful consideration of tag type, position, and methodology:

  • Effective tag composition: Successfully validated composite tags for pax6a include:

    • HBH (His6-Bio-His6) tag followed by a TEV protease cleavage site and FLAG epitope tag (trimeric form)

    • FLAGx3, Bio tag, and HiBiT tag combinations

  • Tag positioning: For minimal functional disruption, insert tags at the N-terminus of the coding sequence. This approach has been validated for pax6a with successful germline transmission of the modified allele .

  • CRISPR-Cas9 optimization: For efficient genomic integration:

    • Use 1.5 fmol of ribonucleoprotein complex per injection

    • Target an optimal cut site 2-4 nucleotides from the intended insertion site (distances of 10 nt show reduced efficiency)

    • Validate crRNA design to minimize off-target effects

  • Donor template design: Optimize donor parameters based on empirical data:

    • Test both target and non-target strand donors

    • For pax6a, shorter 3' homology arms (50-nt) yield better results than longer arms (300-nt)

    • Avoid homopolymeric sequences in homology arms that may adversely affect the repair process

  • Validation strategy: Implement a comprehensive validation approach:

    • Knock-in allele-specific qPCR for both 5' and 3' junctions

    • Functional testing to ensure tag doesn't interfere with protein activity

    • Expression analysis to confirm normal regulation of the tagged allele

How should experiments be designed to distinguish pax6a from pax6b effects?

Designing experiments that effectively discriminate between pax6a and pax6b functions requires:

  • Paralog-specific genetic manipulation:

    • Design CRISPR-Cas9 guide RNAs targeting non-conserved regions to ensure paralog specificity

    • Use morpholinos with carefully validated specificity and appropriate controls

    • Create conditional knockout systems for temporal control of gene inactivation

  • Spatiotemporal resolution:

    • Target analyses to developmental stages and tissues where both paralogs are expressed but potentially serving different functions (e.g., telencephalon)

    • Compare with tissues where only one paralog is expressed (e.g., pancreas for pax6b only, specific regions of the olfactory bulb for pax6a only)

  • Molecular readouts:

    • Use paralog-specific antibodies or tagged knock-in lines to differentiate protein distribution

    • Employ paralog-specific RNA probes for expression analysis

    • Conduct ChIP-seq with paralog-specific antibodies to identify distinct binding targets

  • Rescue experiments:

    • Design rescue constructs with the exact coding sequence of each paralog

    • Create chimeric proteins swapping domains between paralogs to pinpoint functional differences

    • Utilize cross-species rescue (e.g., human PAX6) to test evolutionary conservation of function

  • Control strategies:

    • Include wild-type controls and single-paralog mutants in all experiments with double mutants

    • Use internal controls for expression studies (genes known to be regulated by only one paralog)

    • Implement rigorous statistical analyses to distinguish partial from complete functional redundancy

How can evolutionary conservation analysis inform pax6a research?

Evolutionary conservation analysis provides powerful insights for pax6a research:

  • Sequence conservation mapping: Analyzing conservation across vertebrates reveals functionally critical domains within pax6a. The paired domain and homeodomain show extremely high conservation, indicating their fundamental importance .

  • Regulatory element identification: Non-coding sequence conservation helps identify critical enhancers that control pax6a expression. Multiple evolutionarily conserved regulatory elements control tissue-specific expression patterns and can be validated in transgenic animals .

  • Subfunctionalization evidence: Comparative analysis between species with single PAX6 genes (e.g., mammals) and those with duplicates (teleosts) provides direct evidence of subfunctionalization:

    • Zebrafish pax6a retains most brain-specific regulatory domains

    • Expression patterns of pax6a and pax6b jointly recapitulate the expression of the single PAX6 gene in mammals

  • Functional prediction: Conservation analysis helps predict the functional effects of variants or mutations:

    • Deep mutational scanning of human PAX6 provides insight into which regions tolerate variation

    • Highly conserved residues are more likely to cause significant phenotypes when mutated

    • This allows prediction of benign versus pathogenic variants

  • Synteny analysis: Comparing gene order and neighboring genes across species reveals:

    • Disrupted synteny around pax6a with lost neighboring genes

    • Retention of regulatory elements despite genomic reorganization, highlighting their functional importance

What approaches should be used to resolve contradictory findings on pax6a function?

When faced with contradictory data regarding pax6a function, researchers should:

  • Methodological reconciliation:

    • Compare experimental approaches (morpholino vs. CRISPR, transient vs. stable genetic manipulation)

    • Assess dosage effects—partial vs. complete loss of function

    • Evaluate genetic background differences in zebrafish strains

    • Consider maternal contribution effects that may mask zygotic phenotypes

  • Developmental stage resolution:

    • Contradictions often arise from analyzing different developmental stages

    • Implement time-series analyses to determine whether effects are transient or persistent

    • Use conditional systems to manipulate gene function at specific stages

  • Tissue-specific analysis:

    • Contradictions may reflect tissue-specific requirements

    • Employ tissue-specific knockouts or expression to resolve spatial differences

    • Consider non-cell-autonomous effects where pax6a function in one tissue affects another

  • Molecular compensation mechanism assessment:

    • Genetic compensation (upregulation of pax6b or other genes) may mask pax6a phenotypes

    • Perform RNA-seq on pax6a mutants to identify compensatory changes

    • Create double mutants to test redundancy hypotheses

  • Statistical rigor and sample size:

    • Ensure appropriate statistical power through adequate sample sizes

    • Use consistent statistical methods across comparative studies

    • Implement blinded assessment of phenotypes to reduce observer bias

What are the technical challenges in studying pax6a protein-DNA interactions?

Investigating pax6a protein-DNA interactions presents several technical challenges:

  • Protein production complexities:

    • The paired domain and homeodomain can have distinct DNA-binding preferences

    • Full-length protein may interact differently than isolated domains

    • Post-translational modifications may affect binding characteristics

    • Protein solubility issues during recombinant expression

  • DNA target identification:

    • Pax6 proteins recognize complex binding motifs

    • Cooperative binding with cofactors affects target selection in vivo

    • Chromatin accessibility influences binding site availability

    • Expression level differences affect occupancy patterns

  • In vivo versus in vitro discrepancies:

    • In vitro binding assays may not recapitulate the cellular environment

    • Chromatin structure affects binding in vivo but is absent in most in vitro systems

    • Cofactor availability differs between systems

    • Nuclear concentration of pax6a affects binding site occupancy

  • Technical approach limitations:

    • ChIP-seq requires highly specific antibodies or functional tagged proteins

    • Deep mutational scanning requires appropriate reporter systems

    • SELEX-seq may identify motifs not actually bound in vivo due to chromatin constraints

    • Single-molecule approaches needed for binding kinetics are technically demanding

  • Paralog discrimination:

    • High sequence similarity between pax6a and pax6b creates antibody cross-reactivity issues

    • Binding motifs may overlap, making it difficult to distinguish paralog-specific targets

    • Tagged knock-in approaches must preserve normal protein function and expression levels

How can CRISPR-Cas9 technology be optimized for studying pax6a function?

Optimizing CRISPR-Cas9 approaches for pax6a functional studies requires:

  • Guide RNA design strategies:

    • Target pax6a-specific regions to avoid pax6b off-target effects

    • Use algorithms that predict off-target sites and efficiency

    • Design multiple guide RNAs targeting different exons to compare phenotypes

    • Consider targeting conserved domains versus paralog-specific regions

  • Knock-in optimization parameters:

    • For tag insertion, shorter 3' homology arms (50-nt) outperform longer arms (300-nt) for pax6a

    • The distance between the cut site and insertion site should be minimized (ideally 2-4 nt)

    • Both target and non-target strand donors should be tested empirically

    • Avoid homopolymeric sequences that can adversely affect the repair process

  • Delivery system refinement:

    • Use ribonucleoprotein (RNP) complex (1.5 fmol per injection) rather than DNA or RNA expression

    • Optimize injection timing (one-cell stage preferred) and location

    • Consider nuclear localization signal modifications for improved nuclear targeting

    • Implement purification strategies for injection-grade components

  • Validation approaches:

    • Employ knock-in allele-specific qPCR for both 5' and 3' junctions

    • Sequence multiple F1 offspring to identify precise versus imprecise editing events

    • Test protein expression, localization, and function of tagged/modified variants

    • Perform off-target analysis through whole-genome sequencing of selected lines

  • Phenotypic analysis pipeline:

    • Implement standardized phenotyping protocols

    • Use quantitative metrics rather than qualitative descriptions

    • Compare F0 mosaic phenotypes with stable F1/F2 lines

    • Combine with tissue-specific or inducible systems for temporal control

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.